id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2021-0011-0007,DEA,DEA-2021-0011,Schedules of Controlled Substances: Placement of Amineptine in Schedule I,Rule,,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,,2022-11-17T13:05:24Z,2022-25003,0,0,09000064854bdf02
DEA-2021-0011-0002,DEA,DEA-2021-0011,Aminpetine 8-factor July 2021,Supporting & Related Material,,2021-07-27T04:00:00Z,2021,7,,,2021-07-27T13:52:16Z,,0,0,0900006484c127b0
DEA-2021-0011-0003,DEA,DEA-2021-0011,Amineptine (DHHS) 12-01-2011,Supporting & Related Material,,2021-07-27T04:00:00Z,2021,7,,,2021-07-27T13:52:23Z,,0,0,0900006484c127b1
DEA-2021-0011-0001,DEA,DEA-2021-0011,Schedules of Controlled Substances: Placement of Amineptine in Schedule I,Proposed Rule,,2021-07-22T04:00:00Z,2021,7,2021-07-22T04:00:00Z,2021-09-21T03:59:59Z,2021-08-09T01:00:27Z,2021-15331,0,0,0900006484c078c2